What this site is
The Peptide Progress is a separate, independent publication about research-peptide terminology, analytical testing, certificates of analysis, batch traceability, storage, laboratory sample preparation and supplier due diligence. It is not a clinic, pharmacy or medical service.
Our job is to make technical claims inspectable. We explain what a document can establish, identify what it leaves unknown and link readers to primary or official sources wherever possible.
Editorial independence and supplier references
The Peptide Progress is not owned, sponsored or controlled by ZENTRA Peptides. ZENTRA may be mentioned or linked for the same editorial reasons as other peptide companies: because its public pages are relevant to a directory entry, example or source trail.
Supplier coverage follows these rules:
- No paid rankings, sponsored positions or affiliate links.
- Companies are listed alphabetically unless a page clearly states another neutral order.
- The same comparison criteria are applied to every supplier.
- Company claims are attributed as claims from the company website and dated.
- Inclusion is not endorsement, and omission is not criticism.
- Objective comparisons must be material, relevant, verifiable and based on current public evidence.
- We do not copy logos or imply affiliation, approval or partnership.
Readers should verify the exact batch and current policy themselves. A brand-level statement never replaces sample-level evidence.
Editorial process
- Search intent: identify the real question a reader is trying to answer.
- Source hierarchy: prefer standards, official bodies and primary literature.
- Draft and limits: explain the result and its limitation together.
- Commercial-claim check: attribute supplier claims and remove unsupported superlatives.
- Review: publish a genuine review date and recheck time-sensitive links and claims.
AI-assisted tools may be used to organise research, identify gaps and prepare draft language. Pages are edited against their listed sources before publication; automation is not treated as a source, author credential or substitute for verification. The organisational byline identifies the responsible publisher, and the source list shows the evidence used.
Sourcing standards
- Primary literature and official sources take priority over blogs and marketing.
- A citation supports only the statement beside it; it is not an endorsement.
- Preclinical findings are labelled and are not rewritten as clinical outcomes.
- Illustrative chromatograms and diagrams are identified as illustrations.
- We do not invent ratings, reviews, accreditations or laboratory results.
Corrections and right of reply
Readers and named companies may submit a correction through the contact page. Please include the page, disputed wording and a public source. We correct factual errors promptly, note substantive changes and do not promise favourable coverage in exchange for information.
Funding
The site currently carries no display advertising, sponsored posts or affiliate tracking. If funding or commercial relationships change, this page and affected content will be updated before the relationship influences publication.
Scope and safety
We publish research and laboratory information, not medical advice. We do not provide dosing, injection, administration or personal-use protocols. Laboratory sample-preparation content is written for trained research settings and must be used with applicable safety data, validated procedures and institutional controls.